New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
11:20 EDTRMTI, RMTI, AFFY, AFFY, KERX, KERX, AMAG, AMAGSummer Street's biotech research team holds analyst/industry conference call
Biotech Analyst Research Team, along with an MCRI consultant, discuss dialysis and iron products for end-state renal disorders on an Analyst/Industry conference call to be held on January 31 at 11:30 am.
News For RMTI;AFFY;KERX;AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 26, 2015
15:57 EDTRMTIRockwell Medical says NKF selects four abstracts for Triferic for presentation
Subscribe for More Information
08:48 EDTKERXKeryx management to meet with JMP SEcurities
Subscribe for More Information
March 23, 2015
13:43 EDTKERXKeryx mentioned cautiously in a Seeking Alpha Pro article
Subscribe for More Information
March 20, 2015
07:55 EDTKERXKeryx survey results positive, says Oppenheimer
After surveying 50 nephrologists/nurses/dietitians at U.S. dialysis clinics, Oppenheimer reported that dialysis providers it surveyed expect to prescribe Keryx's Auryxia in 11% of new starts and about 12% of switchers . As a result of this data points and other data from the survey, the firm expects Auryxia prescription trends to improve. It keeps an $18 price target and Outperform rating on the shares.
March 18, 2015
16:51 EDTAMAGAMAG Pharmaceuticals updates current U.S. label of Feraheme
Subscribe for More Information
March 17, 2015
08:35 EDTAMAGAMAG Pharmaceuticals price target raised to $65 from $55 at RW Baird
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use